Given that PYY is secreted from cells of the distal gut there must be signals associated with the response of the proximal gut to food intake that lead to PYY release
What Happens: GLP-1 medications cross the blood-brain barrier Activate receptors in appetite control regions Reduce hunger signals Increase satiety (feeling of fullness) Decrease reward response to food Reduce obsessive thoughts about food What You Experience: Less frequent hunger Feel satisfied with smaller portions Dont think about food constantly Reduced cravings for specific foods Easier to say no to unnecessary eating This is the primary mechanismyou naturally eat less because you genuinely want less food
doi:10.4162/nrp.2010.4.3.229
Grns, a nutrient-dense gummy brand, raised $35 million in Series B funding in 2025, money flowing to products formulated to fill nutritional gaps in bodies consuming 40% fewer calories than baseline. These arent marginal bets
Real-world studies, in parallel, are utilised to address gaps, deliver on local evidence needs and where necessary, further contextualise populations to ensure representativity
If you have been researching Mounjaro for type 2 diabetes in West Lafayette, Indiana, it's designed to manage blood sugar levels in patients with confirmed diabetes
&srotate=0)
